Hudson Biotech
2 registered trials on this site, 2 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity NCT07505745 | MOTS-c | Phase 2 | Recruiting | Hudson Biotech | 120 | Feb 14, 2027 | Apr 1, 2026 |
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo NCT07437560 | Melanotan 2 | Phase 2 | Recruiting | Hudson Biotech | 60 | Feb 14, 2027 | Feb 27, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
